Statistics

Total Visits

Views
Regional analysis of a cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with doce8

Select a period of time:

Number of views in the range

Views
Regional analysis of a cohort compassionate-use program (CUP) and early access program (EAP) with cabazitaxel (Cbz) plus prednisone (P; Cbz plus P) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) previously treated with doce8

Views

Views
November 20230
December 20230
January 20246
February 20240
March 20240
April 20240
May 20242
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
 

Top cities views

Views
Boardman6
Chicago1